These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32105171)

  • 41. Definition of clinical pharmacy as a specialty in clinical practice. Committee on Clinical Pharmacy as a Specialty. American Pharmacy Association.
    Drug Intell Clin Pharm; 1985 Feb; 19(2):149-50. PubMed ID: 3971863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biosimilar competition in the United States: statutory incentives, payers, and pharmacy benefit managers.
    Falit BP; Singh SC; Brennan TA
    Health Aff (Millwood); 2015 Feb; 34(2):294-301. PubMed ID: 25646110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opportunities and challenges in social pharmacy and pharmacy practice research.
    Almarsdóttir AB; Kaae S; Traulsen JM
    Res Social Adm Pharm; 2014; 10(1):252-5. PubMed ID: 23652025
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The future of specialized pharmacy residencies: time for postgraduate year 3 subspecialty training.
    Helling DK; Johnson SG
    Am J Health Syst Pharm; 2014 Jul; 71(14):1199-203. PubMed ID: 24973379
    [No Abstract]   [Full Text] [Related]  

  • 45. Indication or diagnosis should be required on prescriptions.
    Rupp MT; Warholak TL; Murcko AC
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1136-1139. PubMed ID: 34337989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmaceutical care and specialty practice.
    Hepler CD
    Pharmacotherapy; 1993; 13(2 Pt 2):64S-69S. PubMed ID: 8474942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implementation and quality assessment of a pharmacy services call center for outpatient pharmacies and specialty pharmacy services in an academic health system.
    Rim MH; Thomas KC; Chandramouli J; Barrus SA; Nickman NA
    Am J Health Syst Pharm; 2018 May; 75(10):633-641. PubMed ID: 29610290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacy implications of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Okafor MC
    Ann Pharmacother; 2004 Oct; 38(10):1747-9. PubMed ID: 15328392
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacy-related position papers from the APHA Pharmacy Services Committee.
    Bush PJ
    Drug Intell Clin Pharm; 1982 Sep; 16(9):673-9. PubMed ID: 7128459
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of prescriber requirements among US commercial health plans.
    Lenahan K; Panzer AD; Gertler R; Chambers JD
    J Manag Care Spec Pharm; 2021 Dec; 27(12):1757-1762. PubMed ID: 34818091
    [No Abstract]   [Full Text] [Related]  

  • 52. Is specialty patient care affected by exclusivity?
    Swisher R; Blaine N; Hvisdas C
    Am J Health Syst Pharm; 2019 Oct; 76(22):1821-1822. PubMed ID: 31549999
    [No Abstract]   [Full Text] [Related]  

  • 53. The Health Security Act: a case of good news and bad news.
    Wolfgang AP; Rupp MT
    Ann Pharmacother; 1994 Jun; 28(6):802-4. PubMed ID: 7919573
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy.
    Hepler CD
    Pharmacotherapy; 2004 Nov; 24(11):1491-8. PubMed ID: 15537552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
    McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
    Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The three dimensions of managed care pharmacy practice.
    Gouveia WA; Shane R
    Am J Manag Care; 1997 Feb; 3(2):231-9. PubMed ID: 10169257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacy giants shake market.
    Fisher C
    Provider; 1997 Nov; 23(11):52-3, 55-6, 59. PubMed ID: 10173670
    [No Abstract]   [Full Text] [Related]  

  • 59. Collaborative drug therapy management by pharmacists--2003.
    Hammond RW; Schwartz AH; Campbell MJ; Remington TL; Chuck S; Blair MM; Vassey AM; Rospond RM; Herner SJ; Webb CE;
    Pharmacotherapy; 2003 Sep; 23(9):1210-25. PubMed ID: 14524655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.